Swiss drugmaker Roche makes move into China's neuroscience market
As China steps up efforts to adapt its healthcare system to support an aging population, Swiss drugmaker Roche is expanding its neuroscience footprint in the country. The company is confident that advances in diagnosis and targeted therapies can reshape …